UNEXPECTED PATTERNS OF EPSTEIN-BARR-VIRUS GENE-EXPRESSION DURING EARLY STAGES OF B-CELL TRANSFORMATION

被引:14
作者
CHEUNG, RK
MIYAZAKI, I
DOSCH, HM
机构
[1] UNIV TORONTO, HOSP SICK CHILDREN,DEPT PEDIAT,RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA
[2] UNIV TORONTO, HOSP SICK CHILDREN, DEPT IMMUNOL, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA
关键词
D O I
10.1093/intimm/5.7.707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Following Epstein - Barr virus (EBV) binding to its CD21 cell surface receptor, virus internalization, nuclear translocation, and circularization of the viral episome were found to occur within 30 min, immediately preceding the expression of EB nuclear antigen (EBNA)-1 and -2 and latent membrane protein (LMP)-1 and -2 genes. Early viral gene expression was unaffected by blockade of the virus induced, transformation-prerequisite cellular activation pathway (Ca2+ currents, tyrosine phosphorylation, induction of p56Ick, hsp70, and hsp90). Despite life times of only 3 h, antisense (but not sense) oligonucleotides for the above latency genes prevented subsequent transformation. Any one antisense oligonucleotide dramatically depleted transcripts not only of the target gene, but of all other latency genes. The blocking effect of antisense oligonucleotides allowed us to identify a new transformation-prerequisite latency gene near the fused termini. The concerted regulation of EBV gene expression is highly unusual and unexplained but our results imply critical, perhaps regulatory roles for initial latency gene transcripts themselves.
引用
收藏
页码:707 / 716
页数:10
相关论文
共 57 条
[11]   EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 MUTATIONS DEFINE ESSENTIAL DOMAINS FOR TRANSFORMATION AND TRANSACTIVATION [J].
COHEN, JI ;
WANG, F ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2545-2554
[12]  
COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85
[13]   RAPID AMPLIFICATION OF COMPLEMENTARY-DNA FROM SMALL AMOUNTS OF UNFRACTIONATED RNA [J].
DOHERTY, PJ ;
HUESCACONTRERAS, M ;
DOSCH, HM ;
PAN, S .
ANALYTICAL BIOCHEMISTRY, 1989, 177 (01) :7-10
[14]  
DOSCH HM, 1989, J IMMUNOL, V143, P2464
[15]   EBV UTILIZES A UNIQUE ACTIVATION PATHWAY FOR THE TRANSFORMATION OF HUMAN B-CELLS [J].
DOSCH, HM ;
LAM, P ;
HUI, MF ;
HIBI, T ;
CHEUNG, RK .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (09) :833-848
[16]  
DUGAS B, 1988, J IMMUNOL, V141, P4344
[17]   DIAGNOSIS OF NASOPHARYNGEAL CARCINOMA BY DNA AMPLIFICATION OF TISSUE OBTAINED BY FINE-NEEDLE ASPIRATION [J].
FEINMESSER, R ;
MIYAZAKI, I ;
CHEUNG, R ;
FREEMAN, JL ;
NOYEK, AM ;
DOSCH, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) :17-21
[18]   ANTI-B-CELL MONOCLONAL-ANTIBODIES IN THE TREATMENT OF SEVERE B-CELL LYMPHOPROLIFERATIVE SYNDROME FOLLOWING BONE-MARROW AND ORGAN-TRANSPLANTATION [J].
FISCHER, A ;
BLANCHE, S ;
LEBIDOIS, J ;
BORDIGONI, P ;
GARNIER, JL ;
NIAUDET, P ;
MORINET, F ;
LEDEIST, F ;
FISCHER, AM ;
GRISCELLI, C ;
HIRN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1451-1456
[19]   PROTEINS IN NORMAL AND MALIGNANT-CELLS, CROSS-REACTING WITH THE LATENT MEMBRANE-PROTEIN ENCODED BY EPSTEIN-BARR VIRUS [J].
HATZUBAI, A ;
LERNER, RA ;
KLEIN, G ;
SULITZEANU, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (08) :1283-1288
[20]   INDUCTION OF BCL-2 EXPRESSION BY EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 PROTECTS INFECTED B-CELLS FROM PROGRAMMED CELL-DEATH [J].
HENDERSON, S ;
ROWE, M ;
GREGORY, C ;
CROOMCARTER, D ;
WANG, F ;
LONGNECKER, R ;
KIEFF, E ;
RICKINSON, A .
CELL, 1991, 65 (07) :1107-1115